Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion type Assertion NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_head.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion evidence source_evidence_curated NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion SIO_000772 17565644 NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion wasDerivedFrom ctd_human-20150221 NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion wasGeneratedBy ECO_0000218 NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.